Long-term Safety and Efficacy of Imatinib in Pulmonary Arterial Hypertension: Results From a Pilot Open-Label Extension Study

Arterial Hypertension ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension ◽

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

Yearbook of Pulmonary Disease ◽

10.1016/j.ypdi.2012.02.017 ◽

2012 ◽

Vol 2012 ◽

pp. 122-124

Author(s):

C.D. Spradley

Keyword(s):

Arterial Hypertension ◽

Long Term Effects ◽

Open Label ◽

Open Label Extension ◽

S122 Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

10.1136/thorax-2018-212555.128 ◽

2018 ◽

Author(s):

JG Coghlan ◽

N Galiè ◽

S Gaine ◽

R Channick ◽

H-A Ghofrani ◽

...

Keyword(s):

Arterial Hypertension ◽

Open Label ◽

Term Survival ◽

Long Term Survival ◽

Open Label Extension ◽

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

Yearbook of Medicine ◽

10.1016/s0084-3873(12)00230-1 ◽

2012 ◽

Vol 2012 ◽

pp. 275-276

Author(s):

C.D. Spradley

Keyword(s):

Arterial Hypertension ◽

Long Term Effects ◽

Open Label ◽

Open Label Extension ◽

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

International Journal of Cardiology ◽

10.1016/j.ijcard.2015.08.080 ◽

2016 ◽

Vol 202 ◽

pp. 52-58 ◽

Cited By ~ 18

Author(s):

Rolf M.F. Berger ◽

Sheila G. Haworth ◽

Damien Bonnet ◽

Yves Dulac ◽

Alain Fraisse ◽

...

Keyword(s):

Arterial Hypertension ◽

Extension Study ◽

Open Label ◽

Pediatric Formulation ◽

Pulmonary Arterial ◽

Future 2

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2011.08.019 ◽

2011 ◽

Vol 30 (12) ◽

pp. 1327-1333 ◽

Cited By ~ 58

Author(s):

Raymond L. Benza ◽

Werner Seeger ◽

Vallerie V. McLaughlin ◽

Richard N. Channick ◽

Robert Voswinckel ◽

...

Keyword(s):

Arterial Hypertension ◽

Long Term Effects ◽

Open Label ◽

Open Label Extension ◽

Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.08.333 ◽

2016 ◽

Vol 223 ◽

pp. 1072-1073 ◽

Cited By ~ 2

Author(s):

Rolf M.F. Berger ◽

Sheila G. Haworth ◽

Damien Bonnet ◽

Yves Dulac ◽

Alain Fraisse ◽

...

Keyword(s):

Arterial Hypertension ◽

Extension Study ◽

Open Label ◽

Pediatric Formulation ◽

Pulmonary Arterial ◽

Future 2

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Advances in Therapy ◽

10.1007/s12325-021-01898-1 ◽

2021 ◽

Author(s):

Nazzareno Galiè ◽

Sean Gaine ◽

Richard Channick ◽

J. Gerry Coghlan ◽

Marius M. Hoeper ◽

...

Keyword(s):

Arterial Hypertension ◽

Open Label ◽

Term Survival ◽

Long Term Survival ◽

Open Label Extension ◽

103. Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

Rheumatology ◽

10.1093/rheumatology/keu101.024 ◽

2014 ◽

Vol 53 (suppl_1) ◽

pp. i96-i96 ◽

Cited By ~ 1

Author(s):

Edward Keystone ◽

Robert Landewé ◽

Ronald van Vollenhoven ◽

Bernard Combe ◽

Vibeke Strand ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Open Label Extension

P036 LONG-TERM SAFETY AND EFFICACY OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) ANTIBODY SHP647 IN ULCERATIVE COLITIS: AN OPEN-LABEL EXTENSION STUDY (TURANDOT II)

Gastroenterology ◽

10.1053/j.gastro.2019.01.088 ◽

2019 ◽

Vol 156 (3) ◽

pp. S25-S26

Author(s):

Walter Reinisch ◽

William J. Sandborn ◽

Silvio Danese ◽

Xavier Hébuterne ◽

Bruce Salzberg ◽

...

Keyword(s):

Ulcerative Colitis ◽

Cell Adhesion ◽

Adhesion Molecule ◽

Cell Adhesion Molecule ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension ◽

Cell Adhesion Molecule 1

Interim Results from the Ongoing Open-Label Extension of the Phase 2 Trial Evaluating Ralinepag for the Treatment of Pulmonary Arterial Hypertension

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2509 ◽

2019 ◽

Author(s):

V.V. McLaughlin ◽

A.D. Ristic ◽

P. Jansa ◽

E.S. Klings ◽

J.A. Barberà ◽

...

Keyword(s):

Arterial Hypertension ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial ◽

Open Label Extension ◽